Koninklijke DSM NV
AEX:DSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Koninklijke DSM NV
Total Equity
Koninklijke DSM NV
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Koninklijke DSM NV
AEX:DSM
|
Total Equity
€10.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Corbion NV
AEX:CRBN
|
Total Equity
€742.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Akzo Nobel NV
AEX:AKZA
|
Total Equity
€4.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Koninklijke DSM NV
Glance View
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 21,358 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
See Also
What is Koninklijke DSM NV's Total Equity?
Total Equity
10.7B
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's Total Equity amounts to 10.7B EUR.
What is Koninklijke DSM NV's Total Equity growth rate?
Total Equity CAGR 5Y
9%
Over the last year, the Total Equity growth was 15%. The average annual Total Equity growth rates for Koninklijke DSM NV have been 12% over the past three years , 9% over the past five years .
